Chris D. Alafi
Fondateur chez Alafi Capital Co. LLC
Fortune : 61 M $ au 30/04/2024
Profil
Chris D.
Alafi is the founder.
He founded Alafi Capital Co. LLC in 1995 and currently holds the title of Managing Partner.
His current jobs include being a Director at ITI, Inc. (New York) since 2013 and a Director at Nuredis, Inc. His former jobs include being a Director at Cybergold, Inc., Coley Pharmaceutical Group, Inc., and ISTO Technologies, Inc. He was also an Independent Director at Stereotaxis, Inc. from 2011 to 2012 and at Intra-Cellular Therapies, Inc. in 2013.
Additionally, he served as a Professor at Santa Monica College.
Dr. Alafi obtained his undergraduate degree from Pomona College and his graduate and doctorate degrees from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2024 | 850 548 ( 0,82% ) | 61 M $ | 30/04/2024 |
Postes actifs de Chris D. Alafi
| Sociétés | Poste | Début |
|---|---|---|
Alafi Capital Co. LLC
 Alafi Capital Co. LLC Investment ManagersFinance Alafi Capital Co. LLC (Alafi Capital) is a venture capital firm founded by Christopher alafi in 1995. The firm is headquartered in San Francisco, California. | Fondateur | 01/01/2023 |
| ITI, Inc. (New York) | Directeur/Membre du Conseil | 01/01/2013 |
Nuredis, Inc.
 Nuredis, Inc. BiotechnologyHealth Technology Nuredis, Inc. develops treatments for neurodegenerative and neuromuscular diseases. The private company is based in Menlo Park, CA. The company was founded by Stanley N. Cohen. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chris D. Alafi
| Sociétés | Poste | Fin |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Directeur/Membre du Conseil | 21/06/2021 |
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 26/09/2013 |
| STEREOTAXIS, INC. | Directeur/Membre du Conseil | 31/08/2012 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Directeur/Membre du Conseil | - |
Cybergold, Inc.
 Cybergold, Inc. Advertising/Marketing ServicesCommercial Services Cybergold, Inc. provides direct marketing & advertising solutions for on-line advertisers and marketers. It provides internet-based direct marketing and advertising services with programs that reward consumers with cash when they perform actions desired by advertising and marketing clients. The services provided by the company primarily include production and development of marketing programs, delivery of targeted e-mail to its members, design of customer web sites and third party engineering functions. Cybergold was founded by Nat Goldhaber in 1995 and is located in Oakland, CA. | Directeur/Membre du Conseil | - |
Formation de Chris D. Alafi
| Pomona College | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STEREOTAXIS, INC. | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Cybergold, Inc.
Cybergold, Inc. Advertising/Marketing ServicesCommercial Services Cybergold, Inc. provides direct marketing & advertising solutions for on-line advertisers and marketers. It provides internet-based direct marketing and advertising services with programs that reward consumers with cash when they perform actions desired by advertising and marketing clients. The services provided by the company primarily include production and development of marketing programs, delivery of targeted e-mail to its members, design of customer web sites and third party engineering functions. Cybergold was founded by Nat Goldhaber in 1995 and is located in Oakland, CA. | Commercial Services |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
Alafi Capital Co. LLC
Alafi Capital Co. LLC Investment ManagersFinance Alafi Capital Co. LLC (Alafi Capital) is a venture capital firm founded by Christopher alafi in 1995. The firm is headquartered in San Francisco, California. | Finance |
ISTO Technologies, Inc.
 ISTO Technologies, Inc. Medical SpecialtiesHealth Technology ISTO Technologies, Inc. develops and markets clinical solutions for spinal therapy, sports medicine, and trauma. It develops biologic products to rebuild bone, and heal degenerated or damaged cartilage. The company was founded by Joseph Feder and Scott Gill in 1997 and is headquartered in St. Louis, MO. | Health Technology |
| ITI, Inc. (New York) | |
Nuredis, Inc.
Nuredis, Inc. BiotechnologyHealth Technology Nuredis, Inc. develops treatments for neurodegenerative and neuromuscular diseases. The private company is based in Menlo Park, CA. The company was founded by Stanley N. Cohen. | Health Technology |